Journal rankings · indicator year 2012
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2012
Endocrinology, Diabetes and Metabolism journal rankings 2012
124 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 124 ranked journals in 2012. The median journal has an OJR of 0.98, below the world average of 1.00, up 0.02 on 2011; Q1 starts at OJR 1.47. The top three are Endocrine Reviews, Diabetes Care, and Best Practice & Research Clinical Endocrinology & Metabolism.
Ranks and citation indicators: 2012. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2009–2011, the window the 2012 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery610
- Pulmonary and Respiratory Medicine245
- Public Health, Environmental and Occupational Health213
- Cardiology and Cardiovascular Medicine209
- Oncology153
- Epidemiology147
- Infectious Diseases144
- Endocrinology, Diabetes and Metabolism124
- Neurology120
- Radiology, Nuclear Medicine and Imaging112
- Physiology110
- Psychiatry and Mental health109
Show all 42 subfields
- Orthopedics and Sports Medicine85
- Ophthalmology67
- Pediatrics, Perinatology and Child Health67
- Dermatology64
- Hematology60
- Obstetrics and Gynecology55
- Rheumatology53
- Nephrology40
- Pharmacology38
- Complementary and alternative medicine37
- Reproductive Medicine37
- Geriatrics and Gerontology34
- Emergency Medicine32
- Otorhinolaryngology28
- Rehabilitation21
- Critical Care and Intensive Care Medicine20
- Pathology and Forensic Medicine20
- Hepatology16
- Genetics14
- Immunology and Allergy13
- Anesthesiology and Pain Medicine10
- Urology10
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
124 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2011. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2009–2011, the window the 2012 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2009–2011 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2003 to 2012. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 8.66Q1 | 14.45 9.48 down from 2011 | 101 | 50% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 4.19Q1 | 9.48 0.20 up from 2011 | 1,834 | 99% | — | ||
3Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.55Q1 | 7.31 0.49 up from 2011 | 219 | 15% | $4,450 | ||
4The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.33Q1 | 7.79 0.25 up from 2011 | 2,261 | 49% | $3,750 | ||
5Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 3.03Q1 | 6.32 1.85 up from 2011 | 82 | 25% | $5,590 | ||
6DiabetologiaSpringer Science+Business Media · Germany | 2.75Q1 | 6.34 0.35 down from 2011 | 1,118 | 84% | $3,490 | ||
7Diabetes Obesity and MetabolismWiley · United Kingdom | 2.47Q1 | 6.41 1.35 up from 2011 | 526 | 17% | $5,380 | ||
8Endocrine Related CancerBioscientifica · United Kingdom | 2.43Q1 | 5.42 0.58 down from 2011 | 301 | 91% | — | ||
9Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 2.43Q1 | 5.53 0.62 up from 2011 | 214 | 19% | — | ||
10Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.41Q1 | 5.73 0.11 up from 2011 | 145 | 24% | $3,540 | ||
11Journal of Internal MedicineWiley · United Kingdom | 2.36Q1 | 5.33 0.31 up from 2011 | 474 | 48% | $4,780 | ||
12EndocrinologyOxford University Press · United States | 2.21Q1 | 5.24 0.09 down from 2011 | 1,614 | 63% | $3,750 | ||
13ThyroidMary Ann Liebert, Inc. · United States | 2.07Q1 | 3.83 1.16 down from 2011 | 652 | 24% | — | ||
14Journal of EndocrinologyBioscientifica · United Kingdom | 2.03Q1 | 4.53 0.26 up from 2011 | 423 | 94% | — | ||
15European Journal of EndocrinologyOxford University Press · United Kingdom | 1.95Q1 | 4.36 0.01 down from 2011 | 785 | 27% | $4,292 | ||
16Current Diabetes ReviewsBentham Science Publishers · Netherlands | 1.69Q1 | 3.27 0.27 down from 2011 | 124 | 12% | — | ||
17BMC Endocrine DisordersOABioMed Central · United Kingdom | 1.69Q1 | 4.18 0.20 up from 2011 | 62 | 100% | $3,190 | ||
18Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.69Q1 | 3.46 0.11 up from 2011 | 474 | 22% | $3,000 | ||
19World Journal of DiabetesOAHong Kong SAR China | 1.64Q1 | 3.30 1.76 up from 2011 | 56 | 100% | — | ||
20Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.62Q1 | 5.13 0.71 up from 2011 | 275 | 100% | $4,290 | ||
21The Review of Diabetic StudiesOAGermany | 1.60Q1 | 3.22 0.53 up from 2011 | 77 | 100% | — | ||
22Current Diabetes ReportsSpringer Science+Business Media · United States | 1.58Q1 | 3.59 0.35 up from 2011 | 236 | 34% | $4,890 | ||
23International Journal of EndocrinologyOAHindawi Publishing Corporation · United Kingdom | 1.57Q1 | 3.26no change | 97 | 100% | $2,830 | ||
24Clinical EndocrinologyWiley · United Kingdom | 1.57Q1 | 3.29 0.17 down from 2011 | 811 | 20% | $4,250 | ||
25MaturitasElsevier BV · Netherlands | 1.55Q1 | 3.57 0.08 down from 2011 | 610 | 9% | $4,390 | ||
26Diabetes & MetabolismElsevier BV · Netherlands | 1.54Q1 | 2.90 0.07 up from 2011 | 291 | 1% | $4,490 | ||
27Chronic IllnessSAGE Publishing · United Kingdom | 1.53Q1 | 2.71 0.41 up from 2011 | 89 | 47% | $4,150 | ||
28Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.53Q1 | 3.54 0.37 down from 2011 | 344 | 32% | $4,780 | ||
29Diabetic MedicineWiley · United Kingdom | 1.52Q1 | 3.45 0.24 up from 2011 | 853 | 27% | $4,870 | ||
30HORMONESSpringer Science+Business Media · Greece | 1.49Q1 | 2.88 0.59 down from 2011 | 115 | 74% | $2,390 | ||
31Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.47Q1 | 3.28 0.02 up from 2011 | 505 | 34% | — | ||
32Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.46Q2 | 3.07 0.08 down from 2011 | 456 | 100% | $2,990 | ||
33Pediatric DiabetesWiley · Denmark | 1.44Q2 | 2.55 0.57 down from 2011 | 332 | 60% | $2,740 | ||
34Gender MedicineElsevier BV · United States | 1.43Q2 | 2.54 0.09 down from 2011 | 151 | 18% | — | ||
35Endocrine PracticeElsevier BV · United States | 1.40Q2 | 2.89 0.11 up from 2011 | 530 | 11% | $3,480 | ||
36Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.38Q2 | 2.74 0.27 down from 2011 | 996 | 17% | $4,410 | ||
37The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.37Q2 | 2.65 0.17 down from 2011 | 197 | 23% | $4,400 | ||
38Endocrine JournalOAJapan Endocrine Society · Japan | 1.31Q2 | 3.01 0.23 up from 2011 | 431 | 100% | — | ||
39Clinical TherapeuticsElsevier BV · United States | 1.29Q2 | 2.87 0.16 down from 2011 | 727 | 9% | $4,240 | ||
40Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.29Q2 | 3.00 0.62 up from 2011 | 138 | 100% | $2,890 | ||
41Postgraduate MedicineTaylor & Francis · United States | 1.29Q2 | 2.73 0.03 up from 2011 | 396 | 2% | — | ||
42Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.28Q2 | 2.79 0.39 up from 2011 | 117 | 15% | $3,760 | ||
43Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.27Q2 | 3.16 0.64 up from 2011 | 121 | 30% | $2,100 | ||
44Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea | 1.25Q2 | 2.30no 2011 value | 93 | 100% | $500 | ||
45Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.23Q2 | 2.65 0.57 down from 2011 | 678 | 25% | — | ||
46Journal of DiabetesOAWiley · Australia | 1.17Q2 | 2.51 0.54 up from 2011 | 153 | 22% | $3,000 | ||
47Growth Hormone & IGF ResearchElsevier BV · United Kingdom | 1.14Q2 | 2.26 0.63 down from 2011 | 163 | 3% | $3,570 | ||
48PituitarySpringer Science+Business Media · Netherlands | 1.14Q2 | 2.49 0.43 up from 2011 | 199 | 17% | $4,490 | ||
49Journal of Diabetes Science and TechnologySAGE Publishing · United States | 1.12Q2 | 2.51 0.17 down from 2011 | 412 | 100% | $3,900 | ||
50Clinical Drug InvestigationAdis, Springer Healthcare · New Zealand | 1.11Q2 | 2.32 0.18 down from 2011 | 289 | 11% | $4,190 |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery610
- Pulmonary and Respiratory Medicine245
- Public Health, Environmental and Occupational Health213
- Cardiology and Cardiovascular Medicine209
- Oncology153
- Epidemiology147
- Infectious Diseases144
- Endocrinology, Diabetes and Metabolism124
- Neurology120
- Radiology, Nuclear Medicine and Imaging112
- Physiology110
- Psychiatry and Mental health109
- Orthopedics and Sports Medicine85
- Ophthalmology67
- Pediatrics, Perinatology and Child Health67
- Dermatology64
- Hematology60
- Obstetrics and Gynecology55
- Rheumatology53
- Nephrology40
- Pharmacology38
- Complementary and alternative medicine37
- Reproductive Medicine37
- Geriatrics and Gerontology34
- Emergency Medicine32
- Otorhinolaryngology28
- Rehabilitation21
- Critical Care and Intensive Care Medicine20
- Pathology and Forensic Medicine20
- Hepatology16
- Genetics14
- Immunology and Allergy13
- Anesthesiology and Pain Medicine10
- Urology10
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2012. Corpus-wide, 75.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
34 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2009–2011, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2012. Publication window: 2009–2011. How these summaries are calculated
- Ranked journals
- 124
- Window papers (baseline)
- 54,290 +16.1% from indicator year 2009
- Median OJR
- 0.98 +5.2% from indicator year 2009
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2009–2011 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.